 |
|
|
|
 |
|
|
| Article 1 to 10 out of 361
|
|
-
Chickens frequently contaminated with Salmonella and Campylobacter
(19 Mar 2010)
EU study shows: Pathogens are carried over during slaughter from animals to carcasses
The results of a nationwide study coordinated by BfR show that Campylobacter and Salmonella can frequently be detected at the time of slaughter. The pathogens reach the slaughterhouse in intestinal contents or on the feathers of the animals and ......
-
Biologics Sales 2009: Antibodies are the growth drivers
(18 Mar 2010)
Double digit growth rates in classes of antibodies and selected proteins
La Merie S.L. released the new compilation of biologics sales in 2009. In its fourth edition, the report showed again that cancer antibodies and anti-TNF antibodies were leading the field. Sales of insulins grew by 22.4% and consolidated its ......
-
Study evaluates costs and benefits of new chemotherapy drugs
(18 Mar 2010)
New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost. David H. Howard, PhD, and colleagues at Emory University's Rollins School of Public Health ......
-
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
(12 Mar 2010)
The Australian oncology market’s high value and growth opportunities have made it an attractive arena for drug developers to enter. Top 20 cancer therapy brands sales totaled $545m in Australia in 2008, growing at a CAGR of 30% since 2005. ......
-
Obesity and type 2 diabetes market closely linked but vastly different in outlook
(11 Mar 2010)
The independent business analyst forecasts that the antidiabetics market will be worth $37 billion by 2018 up from $20 billion in 2008. This rapid market expansion presents significant opportunities for pharmaceutical companies who are able to ......
-
Big pharmaceutical struggles to benefit from increased CVD drug usage
(04 Mar 2010)
Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to Datamonitor. New research by the independent business analyst predicts that the CVD ......
-
Top Pharmaceutical and Biotech companies face slow down in sales growth over 2008–14
(01 Mar 2010)
Top pharmaceutical and biotech companies face a major slow down in sales growth over 2008–14 according to a new report by independent business analyst Datamonitor. The report title "Pharmaceutical Company Outlook to 2014” considers the forecast ......
-
Cultivation of GM crops increases worldwide, but Europe is missing out
(26 Feb 2010)
More than ever, farmers around the world are turning to GM crops, recognizing the range of benefits that they offer. According to figures released by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA), in 2009, ......
-
Drug companies enter Indonesia and the Philippines
(19 Feb 2010)
An increasing number of Pharmaceutical (Pharma) companies are targeting emerging markets. Indonesia and the Philippines are starting to gain considerable attention thanks to their burgeoning healthcare systems. A recent report by independent ......
-
Vetter wins the Axia Award
(10 Feb 2010)
Vetter has been awarded the 2009 Axia Award for best customer relationship management. Conferred yearly by the global auditing and consulting firm Deloitte, the award is given to medium-sized companies from Baden-Wuerttemberg, Germany, for ......
|
|
|
|
|
Top
